This is the authors' abstract. We don't add key points for this paper.
Hyaluronic acid (HA), a linear polysaccharide composed of alternating β-1,3-glucuronic acid (GlcA) and β-1,4- N -acetylglucosamine (GlcNAc) disaccharide units, is widely utilized in food, pharmaceutical, and cosmetic industries. Conventional in vitro HA biosynthesis is hindered by the reliance on costly nucleotide sugar precursors (UDP-GlcA and UDP-GlcNAc) and inefficient multienzyme coordination. To address these challenges, this study established a cell-free enzymatic cascade system integrating HA de novo synthesis with nucleotide recycling through eight pathway enzymes. By leveraging nucleotide sugar salvage pathways, UDP-GlcA and UDP-GlcNAc were efficiently synthesized from inexpensive monosaccharides, thereby bypassing energy-intensive de novo routes. Soluble expression of Pasteurella multocida hyaluronan synthase ( Pm HAS) was achieved by truncating its membrane-associated domains to enable sequential glycosyl transferase activity in aqueous systems. A dual ATP/UTP regeneration strategy was further implemented to sustain nucleotide supply, eliminating costly downstream purification. Under optimized conditions, the system produced 1.28 g/L HA within 24 h, with a molecular weight range of 1.28 × 10 4 to 1.02 × 10 6 Da and a substrate conversion yield of 65.9%. This work not only provides an economical platform for scalable HA synthesis but also establishes a modular enzymatic blueprint for engineering complex biopolymers, demonstrating broad applicability in synthetic glycobiology.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: